Racial and Ethnic Disparity in Food Allergy in the United States: A Systematic Review

2013 ◽  
Vol 1 (4) ◽  
pp. 378-386 ◽  
Author(s):  
Matthew Greenhawt ◽  
Christopher Weiss ◽  
Marisa L. Conte ◽  
Marlie Doucet ◽  
Amy Engler ◽  
...  
2013 ◽  
Vol 131 (2) ◽  
pp. AB58 ◽  
Author(s):  
Matthew J. Greenhawt ◽  
Christopher C. Weiss ◽  
Marisa Conte ◽  
Marlie Doucet ◽  
Amy Engler ◽  
...  

2014 ◽  
Vol 112 (3) ◽  
pp. 222-229.e3 ◽  
Author(s):  
Corinne A. Keet ◽  
Jessica H. Savage ◽  
Shannon Seopaul ◽  
Roger D. Peng ◽  
Robert A. Wood ◽  
...  

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 1488-P
Author(s):  
NILKA RIOS BURROWS ◽  
YAN ZHANG ◽  
ISRAEL A. HORA ◽  
MEDA E. PAVKOV ◽  
GIUSEPPINA IMPERATORE

2019 ◽  
Author(s):  
Clemens Kruse ◽  
Britney Larson ◽  
Reagan Wilkinson ◽  
Roger Samson ◽  
Taylor Castillo

BACKGROUND Incidence of AD continues to increase, making it the most common cause of dementia and the sixth-leading cause of death in the United States. 2018 numbers are expected to double by 2030. OBJECTIVE We examined the benefits of utilizing technology to identify and detect Alzheimer’s disease in the diagnostic process. METHODS We searched PubMed and CINAHL using key terms and filters to identify 30 articles for review. We analyzed these articles and reported them in accordance with the PRISMA guidelines. RESULTS We identified 11 technologies used in the detection of Alzheimer’s disease: 66% of which used some form of MIR. Functional, structural, and 7T magnetic resonance imaging were all used with structural being the most prevalent. CONCLUSIONS MRI is the best form of current technology being used in the detection of Alzheimer’s disease. MRI is a noninvasive approach that provides highly accurate results in the diagnostic process of Alzheimer’s disease.


Author(s):  
Jyotsana Parajuli ◽  
Judith E. Hupcey

The number of people with cancer and the need for palliative care among this population is increasing in the United States. Despite this growing need, several barriers exist to the utilization of palliative care in oncology. The purpose of this study was to synthesize the evidence on the barriers to palliative care utilization in an oncology population. A systematic review of literature was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. PubMed, CINAHL, and Psych Info databases were used for the literature search. Articles were included if they: 1) focused on cancer, (2) examined and discussed barriers to palliative care, and c) were peer reviewed, published in English, and had an accessible full text. A total of 29 studies (8 quantitative, 18 qualitative, and 3 mixed-methods) were identified and synthesized for this review. The sample size of the included studies ranged from 10 participants to 313 participants. The barriers to palliative care were categorized into barriers related to the patient and family, b) barriers related to providers, and c) barriers related to the healthcare system or policy. The factors identified in this review provide guidance for intervention development to mitigate the existing barriers and facilitate the use palliative care in individuals with cancer.


Sign in / Sign up

Export Citation Format

Share Document